Researchers at Imperial College London and University of Hong Kong are helping reproductive disorder patients with a new robotic platform
Imperial Innovations, the technology transfer office for Imperial College London, is diagnosing active tuberculosis and determining the risk of a latent tuberculosis infection progressing to active tuberculosis.
The LKS Faculty of Medicine of The University of Hong Kong (HKUMed) collaborated with Imperial College London to develop and apply a new robotic platform technology to measure hormone pulse patterns in reproductive disorder patients.
Related Posts
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…